The outcome and the frequency of pathological complete response after neoadjuvant radiotherapy in curative resections for advanced rectal cancer: a population‐based study
Colorectal Disease2015Vol. 18(1), pp. 67–72
Citations Over TimeTop 23% of 2015 papers
Abstract
The rate of ypCR in advanced rectal cancer was about 10%. This phenomenon seems to occur in tumours with a low risk of metastasizing. The contribution of neoadjuvant therapy to ypCR on survival was small or absent.
Related Papers
- → Advances for achieving a pathological complete response for rectal cancer after neoadjuvant therapy(2016)17 cited
- The role and assessment of morphological regression after neoadjuvant therapy in breast cancer patients(2015)
- → Long-term survival results of non-small cell lung cancer patients with complete pathological response after neoadjuvant therapy(2016)1 cited
- → Prognostic Value of Pathological Complete Response After Neoadjuvant Therapy for Locally Advanced Rectal Cancer - Monoinstitutional Ten Years Experience(2011)
- → 70. Long term outcome of pathological complete response patients after neoadjuvant therapy for locally advanced rectal cancer. Monoistitutional prospetictive trial(2012)